Gilbert Wagener
Directeur Technique/Scientifique/R&D chez PHARNEXT SCA
Postes actifs de Gilbert Wagener
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PHARNEXT SCA | Directeur Technique/Scientifique/R&D | 15/06/2023 | - |
Historique de carrière de Gilbert Wagener
Anciens postes connus de Gilbert Wagener
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Directeur Technique/Scientifique/R&D | - | - |
Cell2B - Advanced Therapeutics SA
 Cell2B - Advanced Therapeutics SA BiotechnologyHealth Technology Cell2B - Advanced Therapeutics SA engages in the development of stem cell therapies for immune and inflammatory diseases. Its pipeline consists of cord blood unit expansion and anti-rejection medications. The company was founded by Daniela Couto, David Braga Malta, Francisco dos Santos, and Pedro Andrade in 2011 and is headquartered in Cantanhede, Portugal. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Gilbert Wagener
| Philipps University of Marburg | Doctorate Degree |
| University of Basel | Masters Business Admin |
| Erasmus University Rotterdam | Doctorate Degree |
Statistiques
Internationale
| Portugal | 2 |
| Allemagne | 2 |
| Suisse | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 2 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHARNEXT SCA | Health Technology |
| Entreprise privées | 2 |
|---|---|
Cell2B - Advanced Therapeutics SA
Cell2B - Advanced Therapeutics SA BiotechnologyHealth Technology Cell2B - Advanced Therapeutics SA engages in the development of stem cell therapies for immune and inflammatory diseases. Its pipeline consists of cord blood unit expansion and anti-rejection medications. The company was founded by Daniela Couto, David Braga Malta, Francisco dos Santos, and Pedro Andrade in 2011 and is headquartered in Cantanhede, Portugal. | Health Technology |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Gilbert Wagener
- Expérience